The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular CarcinomaShuji Sumie, Michio Sata, Osamu Nakashima et al.|Annals of Surgical Oncology|2013Cited by 201
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasisHajime Aino, Michio Sata, Shuji Sumie et al.|Molecular and Clinical Oncology|2014Cited by 84
Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective StudyShigeo Shimose, Takuji Torimura, Hideki Iwamoto et al.|Cancers|2020Cited by 78
Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse EventsHideki Iwamoto, Takuji Torimura, Hiroyuki Suzuki et al.|Cancers|2020Cited by 68
Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort studyMasahito Nakano, Masatoshi Tanaka, Ryoko Kuromatsu et al.|Cancer Medicine|2015Cited by 65